BACKGROUND: The potential inclusion of cognitive assessments in the DSM-V and large time-consuming assessments drive a need for short tests of cognitive impairments. We examined the reliability and validity of a brief, 15-minute, version of the Wechsler Adult Intelligence Scale-III (WAIS-III). METHODS: The sample consisted of patients diagnosed with schizophrenia (n=75), their siblings without schizophrenia (n=74) and unrelated healthy controls (n=84). A short WAIS-III consists of the Digit Symbol Coding subtest, and every second (or third) item of Block Design, Information, and Arithmetic. Psychometric analyses were implemented using item-response theory (IRT) to determine the best minimal item short version, while maintaining the sensitivity and reliability of the IQ score. RESULTS: The proposed 15-minute WAIS-III gave reliable estimates of the Full Scale IQ (FSIQ) in all three groups in the sample. The 15-minute (select-item) version yielded an overall R of.95 (R(2)=.92) and IRT yielded an R of .96 (R(2)=.92). All four subtests performed well in differentiating patients, relatives, and healthy controls. Multivariate analysis showed a significant difference in FSIQ-estimate between patients, relatives, and healthy controls, F(2, 202) = 19.00, p < .0001. Regression modelling showed that the three versions of the WAIS had similar associations with functional outcome after a 3-year follow-up. CONCLUSIONS: Our proposed 15-minute version of the WAIS may serve as a useful screening device for general intellectual ability in research or clinical settings, and is recommended when a quick and accurate IQ estimate is desired.
BACKGROUND: The potential inclusion of cognitive assessments in the DSM-V and large time-consuming assessments drive a need for short tests of cognitive impairments. We examined the reliability and validity of a brief, 15-minute, version of the Wechsler Adult Intelligence Scale-III (WAIS-III). METHODS: The sample consisted of patients diagnosed with schizophrenia (n=75), their siblings without schizophrenia (n=74) and unrelated healthy controls (n=84). A short WAIS-III consists of the Digit Symbol Coding subtest, and every second (or third) item of Block Design, Information, and Arithmetic. Psychometric analyses were implemented using item-response theory (IRT) to determine the best minimal item short version, while maintaining the sensitivity and reliability of the IQ score. RESULTS: The proposed 15-minute WAIS-III gave reliable estimates of the Full Scale IQ (FSIQ) in all three groups in the sample. The 15-minute (select-item) version yielded an overall R of.95 (R(2)=.92) and IRT yielded an R of .96 (R(2)=.92). All four subtests performed well in differentiating patients, relatives, and healthy controls. Multivariate analysis showed a significant difference in FSIQ-estimate between patients, relatives, and healthy controls, F(2, 202) = 19.00, p < .0001. Regression modelling showed that the three versions of the WAIS had similar associations with functional outcome after a 3-year follow-up. CONCLUSIONS: Our proposed 15-minute version of the WAIS may serve as a useful screening device for general intellectual ability in research or clinical settings, and is recommended when a quick and accurate IQ estimate is desired.
Authors: Lucia Sideli; Adriano Schimmenti; Daniele La Barbera; Caterina La Cascia; Laura Ferraro; Monica Aas; Luis Alameda; Eva Velthorst; Helen L Fisher; Vincenzo Caretti; Giulia Trotta; Giada Tripoli; Diego Quattrone; Charlotte Gayer-Anderson; Fabio Seminerio; Crocettarachele Sartorio; Giovanna Marrazzo; Antonio Lasalvia; Sarah Tosato; Ilaria Tarricone; Domenico Berardi; Giuseppe D'Andrea; Celso Arango; Manuel Arrojo; Miguel Bernardo; Julio Bobes; Julio Sanjuán; Jose Luis Santos; Paulo Rossi Menezes; Cristina Marta Del-Ben; Hannah E Jongsma; Peter B Jones; James B Kirkbride; Pierre-Michel Llorca; Andrea Tortelli; Baptiste Pignon; Lieuwe de Haan; Jean-Paul Selten; Jim Van Os; Bart P Rutten; Marta Di Forti; Craig Morgan; Robin M Murray Journal: Schizophr Bull Date: 2022-05-07 Impact factor: 7.348
Authors: Laura Ferraro; Caterina La Cascia; Diego Quattrone; Lucia Sideli; Domenica Matranga; Veronica Capuccio; Giada Tripoli; Charlotte Gayer-Anderson; Craig Morgan; Musa B Sami; Pak Sham; Lieuwe de Haan; Eva Velthorst; Hannah E Jongsma; James B Kirkbride; Bart P F Rutten; Alexander L Richards; Laura Roldan; Celso Arango; Miquel Bernardo; Julio Bobes; Julio Sanjuan; Jose Luis Santos; Manuel Arrojo; Ilaria Tarricone; Andrea Tortelli; Andrei Szöke; Cristina Marta Del-Ben; Jean-Paul Selten; Michael Lynskey; Peter B Jones; Jim Van Os; Daniele La Barbera; Robin M Murray; Marta Di Forti Journal: Schizophr Bull Date: 2020-04-10 Impact factor: 9.306
Authors: Claudia Vingerhoets; Desmond Hy Tse; Mathilde van Oudenaren; Dennis Hernaus; Esther van Duin; Janneke Zinkstok; Johannes G Ramaekers; Jacobus Fa Jansen; Grainne McAlonan; Therese van Amelsvoort Journal: J Psychopharmacol Date: 2020-05-25 Impact factor: 4.153
Authors: Gemma Modinos; Alice Egerton; Anna McLaughlin; Katrina McMullen; Veena Kumari; David J Lythgoe; Gareth J Barker; André Aleman; Steve C R Williams Journal: Psychol Med Date: 2017-12-04 Impact factor: 7.723
Authors: Martine van Nierop; Mayke Janssens; Richard Bruggeman; Wiepke Cahn; Lieuwe de Haan; René S Kahn; Carin J Meijer; Inez Myin-Germeys; Jim van Os; Durk Wiersma Journal: PLoS One Date: 2013-11-06 Impact factor: 3.240
Authors: Gemma Modinos; Fatma Simsek; Jamie Horder; Matthijs Bossong; Ilaria Bonoldi; Matilda Azis; Jesus Perez; Matthew Broome; David J Lythgoe; James M Stone; Oliver D Howes; Declan G Murphy; Anthony A Grace; Paul Allen; Philip McGuire Journal: Int J Neuropsychopharmacol Date: 2018-02-01 Impact factor: 5.176
Authors: G Modinos; A McLaughlin; A Egerton; K McMullen; V Kumari; G J Barker; C Keysers; S C R Williams Journal: Transl Psychiatry Date: 2017-04-04 Impact factor: 6.222
Authors: Gemma Modinos; Fatma Şimşek; Matilda Azis; Matthijs Bossong; Ilaria Bonoldi; Carly Samson; Beverly Quinn; Jesus Perez; Matthew R Broome; Fernando Zelaya; David J Lythgoe; Oliver D Howes; James M Stone; Anthony A Grace; Paul Allen; Philip McGuire Journal: Neuropsychopharmacology Date: 2018-01-30 Impact factor: 7.853
Authors: Cécile Henquet; Jim van Os; Lotta K Pries; Christian Rauschenberg; Philippe Delespaul; Gunter Kenis; Jurjen J Luykx; Bochao D Lin; Alexander L Richards; Berna Akdede; Tolga Binbay; Vesile Altınyazar; Berna Yalınçetin; Güvem Gümüş-Akay; Burçin Cihan; Haldun Soygür; Halis Ulaş; Eylem S Cankurtaran; Semra U Kaymak; Marina M Mihaljevic; Sanja S Petrovic; Tijana Mirjanic; Miguel Bernardo; Gisela Mezquida; Silvia Amoretti; Julio Bobes; Pilar A Saiz; Maria P García-Portilla; Julio Sanjuan; Eduardo J Aguilar; Jose L Santos; Estela Jiménez-López; Manuel Arrojo; Angel Carracedo; Gonzalo López; Javier González-Peñas; Mara Parellada; Nadja P Maric; Cem Atbaşoğlu; Alp Ucok; Köksal Alptekin; Meram C Saka; Celso Arango; Michael O'Donovan; Bart P F Rutten; Sinan Gülöksüz Journal: Psychol Med Date: 2020-10-13 Impact factor: 10.592